Severe bloodstream infections: A population-based assessment

Critical Care Medicine

Volumn 32, Issue 4, 2004, Pages 992-997

  Laupland, Kevin B ^a,b   Gregson, Daniel B ^a,b   Zygun, David A ^a   Doig, Christopher J ^a,b   Mortis, Garth ^b   Church, Deirdre L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bacteremia; Bloodstream infection; Intensive care unit; Mortality; Population based; Risk factors

Indexed keywords

ADULT; AGE; AGED; ALCOHOLISM; ARTICLE; BACTEREMIA; CANCER; COMORBIDITY; DEATH; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; GENDER; HEMODIALYSIS; HUMAN; INCIDENCE; INFECTION; INTENSIVE CARE UNIT; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBERTA; BACTEREMIA; COMORBIDITY; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MICROBIAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT ADMISSION; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; RISK FACTORS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; SURVIVAL ANALYSIS;

EID: 1842788877     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000119424.31648.1E     Document Type: Article

References (30)

1. Laupland KB, Zygun DA, Davies HD, et al: Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate. Crit Care Med 2002; 30:2462-2467
2. Forgacs I, Eykyn S, Bradley R: Serious infection in the intensive therapy unit: A 15-year study of bacteremia. Q J Med 1986; 60:773-779
3. Diekema D, Beekman S, Chapin K, et al: Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 2003; 41:3655-3660
4. Alberti C, Brun-Buisson C, Burchardi H, et al: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28:108-121
5. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-1601
6. Harbarth S, Ferriere K, Hugonnet S, et al: Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 2002; 137:1353-1359
7. Brun-Buisson C, Doyon F, Carlet J, et al: Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 1996; 154:617-624
8. Valles J, Leon C, Alvarez-Lerma F, et al: Nosocomial bacteremia in critically ill patients: A multicenter study evaluating epidemiology and prognosis. Clin Infect Dis 1997; 24:387-395
9. Pittet D, Thievent B, Wenzel RP, et al: Bed-side prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996; 153:684-693
10. Richards MJ, Edwards JR, Culver DH, et al: Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21:510-515
11. Geffers C, Koch J, Sohr D, et al: Establishment of a national database for ICU-associated infections. First results from the "Krankenhaus- Infections-Surveillance-System" (KISS). Anaesthesist 2000; 49:732-737
12. Lundberg JS, Perl TM, Wiblin T, et al: Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 1998; 26:1020-1024
13. Davies HD, McGeer A, Schwartz B, et al: Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335:547-554
14. Farley MM, Harvey RC, Stull T, et al: A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993; 328:1807-1811
15. Laupland KB, Church DL, Mucenski M, et al: Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003; 187:1452-1459
16. Doig CJ, Zygun D, Fick G, et al: A description of SOFA in a regional critical care system. Crit Care Med, In Press
17. Church D, Hall P: Centralization of a regional clinical microbiology service: The Calgary experience. Can J Infect Dis 1999; 10:393-402
18. Manns B, Mortis G, Taub K, et al: The Southern Alberta Renal Program database: A prototype for patient management and research initiatives. Clin Invest Med 2001; 24:164-170
19. Knaus W, Draper E, Wagner D, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
20. Cullen D, Civetta J, Briggs B, et al: Therapeutic interventions scoring system: A method of quantitative comparison of patient care. Crit Care Med 1974; 2:57-60
21. Laupland KB, Davies HD, Low DE, et al: Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105:E60
22. Statistics Canada Website. Available at: http//:www.statscan.ca
23. Paltiel O, Ronen I, Polliak A, et al: Two-way referral bias: Evidence from a clinical audit of lymphoma in a teaching hospital. J Clin Epidemiol 1998; 51:93-98
24. Kokmen E, Ozsarfati Y, Beard C, et al: Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol 1996; 49:79-83
25. Quan H, Parsons G, Ghali W: Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002; 40:675-685
26. Shinefeld H, Black S, Fattom A, et al: Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491-496
27. Zaragoza R, Artero A, Camarena JJ, et al: The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003; 9:412-418
28. Ibrahim E, Sherman G, Ward S, et al: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155
29. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
30. Bernard G, Vincent J, Laterre P, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709